{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-231354","form_type":"8-K","ticker":"CRVL","cik":"0000874866","company_name":"CORVEL CORP","filed_at":"2026-05-19T23:30:14+00:00","discovered_at":"2026-05-20T10:05:00.298147+00:00","generated_at":"2026-05-20T10:08:00.152408+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CorVel Q4 FY2026 EPS $0.61 (+20% YoY); FY revenue $959M (+7%)","bullets":["FY revenue $959M (+7% from $896M); FY diluted EPS $2.14 (+17% from $1.83).","Q4 revenue $249M (+7% YoY); Q4 EPS $0.61 (+20% YoY).","Q4 gross profit $63M (25% margin, +9% YoY); ended quarter with $233M cash, no debt.","Repurchased $20.1M of common stock during the quarter.","CERIS health division seeing large payer implementations; P&C services advancing AI tools."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-231354","json":"https://secwatch.observer/filing/0001193125-26-231354.json","markdown":"https://secwatch.observer/filing/0001193125-26-231354.md","text":"https://secwatch.observer/filing/0001193125-26-231354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874866/000119312526231354/0001193125-26-231354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874866/000119312526231354/crvl-20260520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T10:08:00.152408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"97d5098db13d1db18175796209263245d35c7b3c","claim":"CORVEL CORP reported the three months and fiscal year ended March 31, 2026 results: revenue $959 million, EPS $2.14.","evidence_excerpt":"CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $959 million, a 7% increase from $896 million during the fiscal year ended March 31, 2025. Earnings per share for the fiscal year ended March 31, 2026 were $2.14, up 17% compared to $1.83 during the fiscal year ended March 31, 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/874866/000119312526231354/0001193125-26-231354-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months and fiscal year ended March 31, 2026"},{"label":"Revenue","value":"$959 million"},{"label":"EPS","value":"$2.14"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}